Pharmacies Fear Tort Fallout From New Drug Labeling Rule

Law360, Washington (March 6, 2014, 7:11 PM EST) -- The American Pharmacists Association, CVS Caremark Corp. and others urged the U.S. Food and Drug Administration on Thursday to rethink its controversial plan to let generic-drug makers independently change their warning labels, saying the proposed rule could burden consumers with increased costs for generic medicines and expose pharmacists, doctors and others to tort liability.

In a letter to FDA Commissioner Margaret Hamburg, pharmacy lobbying groups and pharmacies said the proposed rule includes revisions to regulations for generic drugs that could have unintended consequences.

They said the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.